Efficacy and safety of FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer after gemcitabine-based therapy: A systematic review and meta-analysis

OBJECTIVE: To undertake a meta-analysis of the treatment effects of different second-line chemotherapy regimens compared with FOLFIRINOX (FOL [folinic acid], F [fluorouracil], IRIN [irinotecan], OX [oxaliplatin]) after failure of gemcitabine-based first-line therapy in patients with pancreatic cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Wenjie, Wang, Lantian, Li, Xiawei, Tang, Kezhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Meta Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087258/
https://www.ncbi.nlm.nih.gov/pubmed/35481414
http://dx.doi.org/10.1177/03000605221093225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087258/
https://www.ncbi.nlm.nih.gov/pubmed/35481414
http://dx.doi.org/10.1177/03000605221093225

Ejemplares similares